10 ML reslizumab 10 MG/ML Injection [Cinqair]
RxNorm concept 1746898, branded drug (sbd). Prescribable name: CINQAIR 100 MG in 10 ML Injection.
- RxCUI
- 1746898
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1746898 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
10 ML Cinqair 10 MG/ML Injection; Cinqair 100 MG per 10 ML Injection
Related concepts
- reslizumab 10 MG/ML (SCDC, consists of)
- reslizumab 10 MG/ML [Cinqair] (SBDC, consists of)
- Injection (DF, has dose form)
- Cinqair (BN, has ingredient)
- 10 ML reslizumab 10 MG/ML Injection (SCD, tradename of)
Linked data
NDCs
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 1746898 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1746898 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1746898. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.